Navigation Links
FDA Establishes New Product Codes for Interbody Devices With Integrated Fixation

CLEVELAND, Nov. 30, 2011 /PRNewswire/ --RSB Spine announced today that it received a revised FDA clearance letter for the InterPlate® System as both an interbody implant with integrated fixation and an anterior screw fixation device.  FDA recently instituted new product codes for stand-alone interbody devices with integrated fixation.   The new code for lumbar interbody devices is OVD, and the new code for cervical interbody devices is OVE.   In addition to these new product codes, the InterPlate retained code KWQ for anterior screw fixation in the spine.

Stand-alone interbody fusion devices were introduced in the U.S. in 2004. They generally consist of an interbody spacer with screw fixation or other mechanisms that engage adjacent vertebrae.  The North American Spine Society (NASS) issued a statement in SpineLine (Coding for Anterior Lumbar Arthrodesis & Instrumentation, November/December, 2007) stating that such devices should be coded as "22558: Arthrodesis, anterior interbody technique..." and "22851: Application of intervertebral biomechanical device…". The guideline further stated that "An additional anterior instrumentation code (22845) is not applicable because there is not a separate construct placed across the vertebral segment."  The American Academy of Professional Coders (AAPC) also adopted the NASS position.

"There has been a great deal of confusion and controversy with stand-alone interbody devices," said Dahari D. Brooks, M.D. of Greensboro Orthopaedics in Greensboro, North Carolina. "The new FDA codes make it easier for surgeons to properly bill and insurers to properly reimburse for these interbody technologies."

"The InterPlate product line is a modular interbody platform and in that regard is different than other stand-alone implants," said John Redmond, CEO of RSB. "The new FDA codes and the retention of our KWQ code help to clarify this difference and provide surgeons with the advantages of a stand-alone implant and the ability to code as a typical anterior plate construct."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at:

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Skyline Diagnostics Establishes Research Collaboration With Janssen
2. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
3. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
4. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
5. Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint(R)
6. Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
7. Schulman Associates IRB Establishes an Institutional Review Board in Canada
8. Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
9. HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
10. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
11. Regado Biosciences Establishes Medical Advisory Board
Post Your Comments:
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
Breaking Biology News(10 mins):